OrbiMed raised a combined $4.3 billion for its ninth flagship heath care VC fund, its fifth Asia-focused fund and its fourth royalties and credit opportunities fund, per Axios.
The firm has been investing globally for over 20 years across the healthcare industry: from early-stage private companies to large multinational corporations. OrbiMed employs a team of over 100 scientific, medical, investment, and other professionals, managing over $17 billion across public and private company investments worldwide.
